Table 1.
Patient characteristics.
| Characteristics | N = 78 |
|---|---|
| Age (year), mean (range) ± SD | 47.3 (18‒77) ± 16.7 |
| Male/female, n (%) | 47 / 31 (60.3 / 39.7) |
| Disease duration (year), mean (range) ± SD | 10.9 (0.3‒38) ± 10.3 |
| Disease extent, n (%) | |
| Extensive colitis | 43 (55.1) |
| Left-sided colitis | 28 (35.9) |
| Proctitis | 7 (9.0) |
| CAI (Lichtiger’s score) mean (range) ± SD | 2.21 (0‒15) ± 2.87 |
| M-MES mean (range) ± SD | 0.87 (0‒3) ± 0.86 |
| S-MES mean (range) ± SD | 1.86 (0‒8) ± 2.13 |
| UCEIS mean (range) ± SD | 1.91 (0‒7) ± 1.94 |
| UCCIS mean (range) ± SD | 16.14 (0‒81.2) ± 19.05 |
| FC (µg/g) mean (range) ± SD | 3448.3 (8.9‒49,300) ± 7945.5 |
| FIT (ng/mL) mean (range) ± SD | 2651.6 (30‒45,900) ± 7195.5 |
| CRP (mg/dL) mean (range) ± SD | 0.39 (0.02‒7.23) ± 1.10 |
| Medication at study, n (%) | |
| Oral 5‒ASA | 53 (67.9) |
| Suppository 5‒ASA | 9 (11.5) |
| Systemic steroids | 9 (11.5) |
| Immunomodulators | 24 (30.8) |
| Biologics | 25 (32.1) |
CAI Clinical activity index, S-MES Sum of Mayo endoscopic subscore, M-MES Maximum Mayo endoscopic subscore, UCEIS Ulcerative colitis endoscopic index of severity, UCCIS Ulcerative colitis colonoscopic index of severity, FC Fecal calprotectin, FIT Fecal immunochemical occult blood test, CRP C-reactive protein, 5-ASA 5-aminosalicylic acid.